Yanxi Liu

发表论文 6 篇 · 总被引 20 次 · h-index 3

代表论文

• Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study (2024 · Rheumatology and Therapy · 被引 12)
• Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT) (2024 · Journal of Rheumatology · 被引 7)
• Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy (2025 · RMD Open · 被引 6)
• Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study. (2026 · Annals of the Rheumatic Diseases · 被引 3)
• A comparative analysis of health technology assessment decision-making for cancer drugs in Germany and England (2026 · Frontiers in Public Health)
• Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China. (2026 · BMC Health Services Research)